Prostate-specific antigen (PSA) measurements' association with metastasis and mortality in patients with nmCRPC (non-metastatic castration resistant prostate cancer).

被引：1
|
作者：
Li, Sophia
Ding, Zhijie
Lin, Jennifer H.
Behl, Ajay S.
Pericone, Chris
Deshmukh, Siddhant
Macomson, Brian
Shore, Neal D.
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Mu Sigma Business Solut Pvt Ltd, Bengaluru, India
[4] Carolina Urol Res Ctr, Myrtle Beach, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17058
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of prostate-specific antigen (PSA) trajectories with risk for metastasis and mortality in non-metastatic castration-resistant prostate cancer (nmCRPC).
    Li, Sophia
    Ding, Zhijie
    Lin, Jennifer H.
    Behl, Ajay S.
    Pericone, Chris
    Macomson, Brian
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Association of prostate-specific antigen (PSA) trajectories with risk for metastasis and mortality in non-metastatic castration-resistant prostate cancer (nmCRPC).
    Li, Sophia
    Ding, Zhijie
    Lin, Jennifer H.
    Behl, Ajay S.
    Pericone, Chris
    Macomson, Brian
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [3] ASSOCIATION OF PROSTATE-SPECIFIC ANTIGEN TRAJECTORIES WITH MORTALITY IN VETERANS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Freedland, Stephen
    Young-Xu, Yinong
    Li, Sophia
    Pilon, Dominic
    Bhak, Rachel
    Duchesneau, Emilie
    Hellstern, Michael
    Behl, Ajay
    Lefebvre, Patrick
    Fuld, Alexander
    JOURNAL OF UROLOGY, 2019, 201 (04): : E497 - E498
  • [4] Real-world prostate-specific antigen (PSA) response and disease progression among patients with non-metastatic castration-resistant prostate cancer (nmCRPC) initiated on apalutamide (APA).
    Lowentritt, Benjamin H.
    Du, Shawn
    Rossi, Carmine
    Kinkead, Frederic
    Waters, Dexter
    Moore, Bronwyn
    Lefebvre, Patrick
    Pilon, Dominic
    Muser, Erik
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [5] DIRECT MEDICAL COSTS IN PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (nmCRPC) IN COLOMBIA
    Lopez-Cabra, C.
    Roa, M.
    Torres, L.
    Salcedo, Mejia F.
    Camerano, R.
    Chaparro, Vivanco F. A.
    Gomez, De la Rosa F.
    Alvis, Zakzuk N. J.
    Alvis, Zakzuk N. R.
    Fernandez, Mercado J.
    Estrada, H.
    Estrada, S.
    Martinez, E.
    Marrugo, R.
    VALUE IN HEALTH, 2024, 27 (06) : S118 - S118
  • [6] Efficacy and safety of darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and a prostate-specific antigen doubling time (PSADT) > and ≤ 6 months.
    Schlack, K.
    Smith, M. R.
    Shore, N. D.
    Tammela, T. L. J.
    Ulys, A.
    Vjaters, E.
    Polyakov, S.
    Jievaltas, M.
    Luz, M.
    Alekseev, B.
    Kuss, I.
    Le Berre, M. -A.
    Snapir, A.
    Sarapohja, T.
    Fizazi, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 223 - 223
  • [7] Association of prostate specific-antigen doubling time (PSADT) with metastasis-free survival (MFS) and overall survival (OS) in non-metastatic castration-resistant prostate cancer (nmCRPC).
    Lin, Jennifer H.
    Macomson, Brian
    Tunceli, Ozgur
    Pericone, Chris
    Behl, Ajay S.
    Deshmukh, Siddhant
    Shore, Neal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
    Lowentritt, Benjamin
    Brown, Gordon
    Pilon, Dominic
    Ellis, Lorie
    Germain, Guillaume
    Rossi, Carmine
    Lefebvre, Patrick
    Kernen, Kenneth
    Sieber, Paul
    Shore, Neal
    UROLOGY, 2022, 166 : 182 - 188
  • [9] Impact of new systemic therapies on outcomes of patients with non-metastatic castration resistant prostate cancer (nmCRPC).
    Vicier, Cecile
    Xie, Wanling
    Hamid, Anis
    Evan, Carolyn
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [10] Predictors of overall survival (OS) in veterans with non-metastatic castration resistant prostate cancer (nmCRPC).
    Fuld, Alexander D.
    Young-Xu, Yinong
    Li, Sophia
    Pilon, Dominic
    Bhak, Rachel
    Duchesneau, Emilie
    Hellstern, Michael
    Kamstra, Rhiannon
    Behl, Ajay S.
    Lefebvre, Patrick
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345